glp 1 roche Roche's $2.7B weight-loss wager delivers early oral GLP-1 win After missing the first wave

New real-world evidence suggests that staying on GLP-1 therapy may be critical for sustaining cardiovascular protection, while even short interruptions could diminish long-term benefits in people with type 2 diabetes

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints

Not all GLP-1 supplements are built the same

[DOI] [PubMed] [Google Scholar] 241.Zheng W, Pan H, Wei L, Gao F, Lin X

If you are prescribed Mounjaro (or Zepbound, which is also FDA-approved for moderate to severe OSA in adults with obesity), you may still occasionally experience these symptoms